Insulins Insulin
Found 9 free book(s)
Type 2 Diabetes Adult Outpatient Insulin Guidelines
www.srfmr.orgBASAL INSULIN Long-acting: Glargine (Lantus®) Detemir (Levemir®) Intermediate-acting: NPH Note: NPH insulin has elevated risk of hypoglycemia so use with extra caution6,8,15,17,25,32 • Basal insulin is best starting insulin choice for most patients (if fasting glucose above goal).6,7,8 • Start one of the intermediate-acting or long-acting insulins listed above. 6,7 Start insulin at night. 8
REVIEW OF THE EVIDENCE COMPARING INSULIN (HUMAN …
www.who.intAnalogue insulins 4 Executive Summary Background: The WHO has requested an assessment of the efficacy and safety of analogue insulins, in comparison to human or animal insulin, for the treatment of Type 1 and 2 diabetes.
Mixing Insulins: 10 Units of Regular and 20 Units of NPH
wps.prenhall.com490 UNIT IV / Responses to Altered Endocrine Function Lipodystrophy. Lipodystrophy (hypertrophy of subcuta-neous tissue) or lipoatrophy (atrophy of subcutaneous tissue) may result if the same injection sites are used repeatedly, espe-cially with pork and beef insulins.
HIGHLIGHTS OF PRESCRIBING INFORMATION Hypoglycemia: …
pi.lilly.comChanges in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia [see Warnings and Precautions (5.3)]or hyperglycemia.
PRODUCT MONOGRAPH LANTUS - Sanofi
products.sanofi.caPage 1 of 62 . PRODUCT MONOGRAPH . LANTUS®. Insulin glargine injection (rDNA origin) Solution for injection 100 U/mL . ATC code: A10AE04 . Antidiabetic Agent
HUMALOG MIX25 and MIX50 - Medsafe
www.medsafe.govt.nzHUMALOG® CARTRIDGES 1 HUMALOG®, HUMALOG® MIX25 and HUMALOG® MIX50 CARTRIDGES Insulin Lispro (rbe) Consumer Medicine Information . What is …
How to Switch Between Insulin Products - mysccg.com
www.mysccg.comDetail-Document #251005 − This Detail-Document accompanies the related article published in − PHARMACIST’S LETTER / PRESCRIBER’S LETTER October 2009 ~ Volume 25 ~ Number 251005
ation based on Drugstore.com (if available). Prepared 11/08.
courses.washington.eduInformation based on manufacturer prescribing information and clinical studies. Price inform. ation based on Drugstore.com (if available). Prepared 11/08.
HIGHLIGHTS OF PRESCRIBING INFORMATION Carry
pi.lilly.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BASAGLAR®is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Limitations of Use BASAGLARis not recommendedfor the treatment of …